You are viewing: Europe Empty Capsules Market analysis
Part of: Empty Capsules Market (Global)

The Europe Empty Capsules Market was valued at $944.6 Million in 2025 and projected to reach to $1233.2 Million by 2030, representing a compound annual growth rate of 5.5%. Europe's empty capsules market is poised for steady expansion through 2030, driven by the region's mature pharmaceutical manufacturing base and increasing adoption of capsule-based drug delivery systems.

Europe Empty Capsules Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Empty Capsules Market Trends and Insights

  • This growth in Europe reflects increasing demand from pharmaceutical manufacturers seeking reliable encapsulation solutions for both prescription and over-the-counter medications.
  • Europe's mature healthcare infrastructure and stringent regulatory standards drive adoption of high-quality empty capsules across the region. The European market benefits from established pharmaceutical manufacturing hubs and a growing preference for plant-based and vegetarian capsule alternatives.
  • In Europe, regulatory compliance with European Medicines Agency (EMA) standards ensures consistent product quality and safety.
  • Between 2025 and 2030, Europe is anticipated to see sustained growth driven by innovations in capsule technology and expanding nutraceutical applications across the continent..

Key Market Statistics

  • CAGR (2025-2030) 5.5% CAGR
  • Market Size, 2025 ~USD 944.6 Million
  • Forecast, 2030 ~USD 1233.2 Million
  • Geography Europe

Europe Empty Capsules Market Overview

Market Leadership by Germany :

Germany dominates Europe's empty capsules market with a valuation of $344.4 million in 2025, driven by its robust pharmaceutical manufacturing sector and stringent quality standards that favor premium encapsulation solutions.

UK and France as Secondary Hubs :

The UK ($233.7 million) and France ($98.8 million) represent significant secondary markets, supported by established pharmaceutical companies and growing demand for specialized capsule formulations in both prescription and OTC segments.

Steady 5.5% CAGR Through 2030 :

Europe's empty capsules market is projected to grow from $944.6 million in 2025 to $1,233.2 million by 2030 at a 5.5% CAGR, reflecting consistent demand from pharmaceutical manufacturers across the region.

Emerging Opportunities in Southern Europe :

Italy ($62.5 million) and Spain ($47.2 million) present growth opportunities as pharmaceutical outsourcing and contract manufacturing expand, supported by improving healthcare infrastructure and regulatory harmonization.

Europe Empty Capsules Market Dynamics

  • The market benefits from stringent regulatory frameworks that ensure product quality and safety, attracting both multinational and regional manufacturers seeking reliable encapsulation partners.
  • Germany's leadership position reflects its status as a pharmaceutical hub, while emerging markets in Southern and Eastern Europe present untapped growth potential. The forecast growth to $1,233.2 million by 2030 is underpinned by rising demand for personalized medicine, plant-based capsule alternatives, and advanced formulation technologies.
  • European manufacturers are increasingly investing in sustainable and innovative capsule solutions to meet evolving regulatory requirements and consumer preferences.
  • Strategic partnerships between capsule suppliers and pharmaceutical companies will further accelerate market penetration across the region..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Europe's empty capsules market is valued at $944.6 million in 2025 and projected to reach $1,233.2 million by 2030 at a 5.5% CAGR.
    • Europe's stringent EMA regulatory standards and mature pharmaceutical infrastructure support consistent demand for high-quality encapsulation solutions.
    • Plant-based and vegetarian capsule alternatives are gaining traction in Europe, driven by consumer preference for sustainable and clean-label products.
    • Europe's established manufacturing ecosystem and innovation in capsule technology position the region for steady growth through 2030.

    Empty Capsules Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SUSTAINED-RELEASE CAPSULES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.6% from 2025 to 2030
    Largest Segment IMMEDIATE-RELEASE CAPSULES (Functionality)
    Market Size Base Year (Billions) ~USD 3.19 (2025)
    Revenue Forecast (Billions) ~USD 4.19 (2030)
    Segments Covered Type, Raw Material, Functionality, Size, Therapeutic Application, End User

    Europe Empty Capsules Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Gelatin Capsules
    • Non-Gelatin Capsules

    By Raw Material

    • Bonemeal Gelatin
    • Bovine-Derived Gelatin
    • Hydroxypropyl Methylcellulose (Hpmc)
    • Other Gelatin Sources
    • Porcine Gelatin
    • Pullulan & Starch

    By Functionality

    • Delayed-Release Capsules
    • Immediate-Release Capsules
    • Sustained-Release Capsules

    By Size

    • Size 0
    • Size 00
    • Size 000
    • Size 1
    • Size 2
    • Size 3
    • Size 4
    • Size 5

    By Therapeutic Application

    • Antacid & Antiflatulent Preparations
    • Anti-Inflammatory Drugs
    • Antianemic Preparations
    • Antibiotic & Antibacterial Drugs
    • Cardiovascular Therapy Drugs
    • Cough & Cold Drugs
    • Dietary Supplements
    • Other Therapeutic Applications

    By End User

    • Cosmetic Industry
    • Nutraceutical Industry
    • Pharmaceutical Industry
    • Research Laboratories

    REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    COSMETIC INDUSTRY20.520.821.522.423.424.525.827.14.8
    NUTRACEUTICAL INDUSTRY83.985.188.392.597.1102.3107.9114.15.3
    PHARMACEUTICAL INDUSTRY105.6107.1111116.1121.9128.2135.1142.75.2
    RESEARCH LABORATORIES99.29.49.810.210.611.111.74.3
    TOTAL219222.2230.2240.8252.7265.6280295.75.1

    EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    COSMETIC INDUSTRY82.483.687.191.195.6100.5105.9111.95.1
    NUTRACEUTICAL INDUSTRY339.2344.7360.5378.8399.3421.7446.5473.65.6
    PHARMACEUTICAL INDUSTRY428.7435.6455.1477.7503.1530.7561.3594.85.5
    RESEARCH LABORATORIES39.740.441.943.745.747.950.352.94.8
    TOTAL890904.3944.6991.31043.71100.911641233.25.5

    Target Audience

    • Pharmaceutical Manufacturers : European pharma companies require detailed market data to optimize capsule sourcing strategies, evaluate supplier capabilities, and plan product portfolio expansion across regulated markets.
    • Capsule Suppliers & Manufacturers : Encapsulation solution providers need country-level insights to identify growth markets, assess competitive intensity, and develop localized product offerings aligned with regional pharmaceutical demand.
    • Contract Manufacturing Organizations (CMOs) : CMOs operating in Europe require market intelligence to benchmark service offerings, identify capacity expansion opportunities, and support clients' formulation development with data-driven insights.
    • Investment & Private Equity Firms : Investors evaluating pharmaceutical supply chain opportunities need comprehensive European market data to assess acquisition targets, growth potential, and strategic consolidation opportunities in the capsule sector.
    • Healthcare Consultants & Analysts : Industry consultants and research analysts require granular European market data to support client advisory work, competitive benchmarking, and strategic planning in pharmaceutical manufacturing and packaging.

    Key Companies in the Europe Empty Capsules Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    HELM AGGermanyPrivate CompanyBasic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers,
    SUNIL HEALTHCARE LIMITEDIndiaPublic CompanyStandard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules,
    NATURAL CAPSULES LIMITEDIndiaPublic CompanyStandard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules,
    ANHUI HUANGSHAN CAPSULE CO., LTD.ChinaPublic CompanyVacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble),

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.

    ALLERGAN PLC

    Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.

    HELM AG

    Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.

    SUNIL HEALTHCARE LIMITED

    Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.

    NATURAL CAPSULES LIMITED

    Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.

    ANHUI HUANGSHAN CAPSULE CO., LTD.

    Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 1454.3 Million · 5.7% wtd CAGR ·
    Asia Pacific
    ~USD 1198.2 Million · 6% wtd CAGR ·
    Latin America
    ~USD 210.4 Million · 5% wtd CAGR ·
    Middle East
    ~USD 68.5 Million · 3.6% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 344.4 Million
    UKUSD 233.7 Million
    FranceUSD 98.8 Million
    ItalyUSD 62.5 Million
    SpainUSD 47.2 Million
    NetherlandsUSD 33.8 Million
    Rest Of EuropeUSD 162.3 Million

    Country market size visualization

    Germany
    USD 344.4 Million
    UK
    USD 233.7 Million
    France
    USD 98.8 Million
    Italy
    USD 62.5 Million
    Spain
    USD 47.2 Million
    Netherlands
    USD 33.8 Million
    Rest Of Europe
    USD 162.3 Million

    Reasons to Buy this Report

    • Country-Level Market Segmentation : Access detailed market sizing for Germany, UK, France, Italy, Spain, Netherlands, and Rest of Europe to identify high-potential markets and tailor regional strategies accordingly.
    • Competitive Landscape Intelligence : Understand market dynamics specific to Europe's pharmaceutical manufacturing ecosystem, including key players, market consolidation trends, and competitive positioning across major European markets.
    • Growth Trajectory & Forecasting : Leverage 5-year projections (2025-2030) with 5.5% CAGR to plan capacity investments, supply chain optimization, and market entry strategies with confidence in regional demand trends.
    • Regulatory & Compliance Insights : Gain insights into Europe's stringent pharmaceutical regulations, quality standards, and compliance requirements that shape capsule specifications and manufacturing practices across the region.
    • Strategic Market Positioning : Identify emerging opportunities in underserved European markets and develop targeted go-to-market strategies based on country-specific pharmaceutical manufacturing capabilities and demand patterns.

    Frequently asked questions

    What is the current size of Europe's empty capsules market?

    Europe's empty capsules market is valued at $944.6 million in 2025 and is projected to grow to $1,233.2 million by 2030.

    What is the growth rate for empty capsules in Europe?

    Europe's empty capsules market is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2030.

    What regulatory standards govern empty capsules in Europe?

    In Europe, empty capsules must comply with European Medicines Agency (EMA) standards and European Pharmacopoeia (Ph. Eur.) requirements to ensure quality and safety.

    What types of capsules are most popular in Europe?

    Europe shows strong demand for both gelatin and plant-based capsules, with increasing preference for vegetarian and vegan alternatives driven by consumer sustainability concerns.

    Which industries drive demand for empty capsules in Europe?

    In Europe, demand is driven by pharmaceutical manufacturers, nutraceutical companies, and dietary supplement producers seeking reliable encapsulation solutions.

    RESEARCH METHODOLOGY

    This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.

    The following is a breakdown of the primary respondents:

    Empty Capsules Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    A list of the major global players operating in the empty capsules market was generated.

    The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)

    The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.

    The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.

    All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Empty Capsules Market Size: Bottom-up and Top-down Approach

    Empty Capsules Market

    Data Triangulation

    After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.

    Stakeholders

    • Empty Capsules Manufacturing Companies
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Regulatory Bodies

    Report Objectives

    • To define, describe, and forecast the empty capsules market based on type, raw material, functionality, size, therapeutic application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the empty capsules market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global Empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the empty capsules market
    • To benchmark players within the empty capsules market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business strategies and product footprints.

    Get the Full Empty Capsules Market Report

    Full forecast, segment splits, and company analysis for all Empty Capsules Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status